These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9177436)
1. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7? Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291 [TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10). Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006 [TBL] [Abstract][Full Text] [Related]
5. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection. Al-Mawali A; Pinto AD; Al-Zadjali S Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396 [TBL] [Abstract][Full Text] [Related]
6. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors. Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations. Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014 [TBL] [Abstract][Full Text] [Related]
8. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]
9. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells. Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217 [TBL] [Abstract][Full Text] [Related]
10. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias. da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291 [TBL] [Abstract][Full Text] [Related]
11. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome. Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818 [TBL] [Abstract][Full Text] [Related]
12. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Huang S; Law P; Young D; Ho AD Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056 [TBL] [Abstract][Full Text] [Related]
13. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow]. Wu HH; Cao H; Wang YZ; Wang DX; Lin HR; Qin YZ; Chang Y; Hao L; Li LD; Li JL; Ruan GR; Huang XJ; Liu YR Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555 [TBL] [Abstract][Full Text] [Related]
14. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells. Opie TM; Shields LE; Andrews RG Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814 [TBL] [Abstract][Full Text] [Related]
15. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis. Del Cañizo MC; Galende J; Mota A; Orfao A; Martinez A; Almeida J; San Miguel JF Leuk Res; 1997 Jul; 21(7):651-6. PubMed ID: 9301686 [TBL] [Abstract][Full Text] [Related]
16. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia. Lewis NR; Pallis M; Russell NH Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243 [TBL] [Abstract][Full Text] [Related]
17. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162 [TBL] [Abstract][Full Text] [Related]
18. CD117/CD34 expression in leukemic blasts. Wells SJ; Bray RA; Stempora LL; Farhi DC Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172 [TBL] [Abstract][Full Text] [Related]
19. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230 [TBL] [Abstract][Full Text] [Related]
20. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager. Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]